Back to Search
Start Over
Interrelations between COVID-19 and other disorders
- Source :
- Clinical Immunology, Clinical Immunology (Orlando, Fla.)
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
-
Abstract
- The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread across the globe to-date. The disease ranges from asymptomatic carriers to symptoms such as fever, sore throat, cough, lung infections, and in severe cases, acute respiratory distress syndrome, sepsis, and death. As many as 50% of patients reported having at least one comorbidities with COVID-19 upon hospital admission. Hypertension, diabetes, chronic obstructive pulmonary disease, obesity, and cardiovascular diseases are among the most commonly reported. Comorbidities are contributing to acute disease prognosis and increased risk of severe symptoms. Around 70% of patients who require ICU care have been observed to have comorbidities. This review intends to understand how some of these comorbidities affect the disease’s prognosis and how severe the outcome can be expected.<br />Graphical abstrat Unlabelled Image
- Subjects :
- 0301 basic medicine
Comorbidity
Review Article
Disease
OR, odd ratio
medicine.disease_cause
Comorbidities
Pulmonary Disease, Chronic Obstructive
0302 clinical medicine
Sore throat
ARBs, angiotensin II receptor blockers
Immunology and Allergy
HCT, hematopoietic cell transplant
Coronavirus
Novel coronavirus
Diabetes
SOT, solid organ transplant
Cardiovascular diseases
medicine.anatomical_structure
SARS-CoV-2 outcome
Hypertension
T1D, type 1 diabetes
medicine.symptom
medicine.medical_specialty
RR, relative risk, risk ratio
Immunology
T2D, type 2 diabetes
ACE2, angiotensin-converting enzyme 2
Sepsis
03 medical and health sciences
Internal medicine
Diabetes mellitus
Diabetes Mellitus
medicine
Humans
Obesity
Preexisting condition
ARDS, acute respiratory distress syndrome
Asthma
Severe outcome
Lung
SARS-CoV-2
business.industry
COVID-19
CRS, cytokine activation or release syndrome
medicine.disease
AMI, acute myocardial infarction
IMV, invasive mechanical ventilation
030104 developmental biology
COPD, chronic obstructive pulmonary disease
business
Asymptomatic carrier
030215 immunology
Subjects
Details
- ISSN :
- 15216616
- Volume :
- 224
- Database :
- OpenAIRE
- Journal :
- Clinical Immunology
- Accession number :
- edsair.doi.dedup.....5ba2a527be688a57a721be1379615577
- Full Text :
- https://doi.org/10.1016/j.clim.2020.108651